BriaCell Therapeutics ($BCTX) Reports Q3 Loss Narrower Than Expected at $1.64 Per Share

By
Staff Writer
-
2
BriaCell Therapeutics (BCTX) reported Q3 2025 financial results after market close.

The company posted an earnings loss of $1.64 per share, better than the estimated loss of $1.76 per share.

This compares to earnings of $0.11 per share from the same quarter last year.